{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:18:11Z","timestamp":1760955491620},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.semerg.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T08:10:11Z","timestamp":1398327011000},"page":"e91-e94","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rabdomiolisis secundaria a simvastatina y fenofibrato"],"prefix":"10.1016","volume":"40","author":[{"given":"M.J.","family":"Forcadell-Peris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"de Diego-Cabanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2014.01.007_bib0005","article-title":"Muscle injury associated with lipid lowering drugs","author":"Rosendon","year":"2012","journal-title":"Up-to-Date"},{"key":"10.1016\/j.semerg.2014.01.007_bib0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1138-3593(07)73859-5","article-title":"Rabdomi\u00f3lisis probablemente debida a interacci\u00f3n entre fluconazol y simvastatina","volume":"33","author":"Tres Belzunegui","year":"2007","journal-title":"SEMERGEN"},{"key":"10.1016\/j.semerg.2014.01.007_bib0015","unstructured":"FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. December 2011. [\u00faltima actualizaci\u00f3n 1 Mar 2013]. Disponible en: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm256581.htm"},{"key":"10.1016\/j.semerg.2014.01.007_bib0020","unstructured":"SEA news: La Sociedad Espa\u00f1ola de Ateriosclerosis defiende la seguridad de las estatinas para tratamientos hipocolesterolemiantes. [Jun 2012]. Disponible en: http:\/\/www.searteriosclerosis.org\/news-sea-news"},{"key":"10.1016\/j.semerg.2014.01.007_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0003319710395560","article-title":"Statin myopathy: Significant problem with minimal awareness by clinicians and no emphasis by clinical investigators","volume":"62","author":"Whayne","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.semerg.2014.01.007_bib0030","first-page":"27","article-title":"Rabdomiolisis por estatinas: reporte de un caso fatal y revisi\u00f3n de la literatura","volume":"1","author":"Delgado-Leal","year":"2012","journal-title":"Revista Mejicana Cardiolog\u00eda"},{"key":"10.1016\/j.semerg.2014.01.007_bib0035","first-page":"285","article-title":"Rhabdomyolysis and acute kidney injury","volume":"365","author":"Bosch","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2014.01.007_bib0040","series-title":"Colesterol i risc coronari [En linia]","author":"Baena D\u00edez","year":"2009"},{"key":"10.1016\/j.semerg.2014.01.007_bib0045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: Statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2014.01.007_bib0050","doi-asserted-by":"crossref","first-page":"e28124","DOI":"10.1371\/journal.pone.0028124","article-title":"Statin-associated a muscular and renal adverse events: Data mining of the public version of the FDA adverse event reporting system","volume":"6","author":"Sakaeda","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.semerg.2014.01.007_bib0055","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.amjcard.2012.06.050","article-title":"Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia","volume":"110","author":"Guo","year":"2012","journal-title":"Am J Cardiol"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359314000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T13:26:22Z","timestamp":1538659582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359314000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1138359314000628"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2014.01.007","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabdomiolisis secundaria a simvastatina y fenofibrato","name":"articletitle","label":"Article Title"},{"value":"SEMERGEN - Medicina de Familia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}